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Abstract
Background: Life-long regular use of drugs is necessary in chronic diseases like asthma and COPD. There
are several methods to improve adherence including patient information and education; however, their
effectiveness on the basis of practical experience is often lower than originally planned and expected. Our
objective is to develop a patient information material based on the recommendations of patients and their
treating healthcare professionals to fulfill their needs.
Methods: A survey was conducted among pulmonologists (N = 262), asthma nurses (N = 102), general
practitioners (N = 321) and patients with obstructive pulmonary disease (N = 978) using on line questionnaires.
Results: All surveyed population would prefer to use 1 to 5 pages long, A5 format patient information material based
on topics considered important by patients that is appropriately segmented with pictures as well as supplementary
information cards adapted to the life situation of patients and the severity of their disease. Questioned population
(whose mean age was 57.2) preferred highly informative printed material.
Conclusions: For more effective information and improvement of adherence we recommend newly structured patient
information sheets and information cards with content discussed with the targeted patients and their healthcare professionals.
Customized, patient-centered information materials could improve the efficiency of patient education and
make the follow-up of the various therapeutic plans easier for patients.
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Background
The number of patients with obstructive pulmonary
disease (asthma, COPD) has increased worldwide in
the last decade. These patients are not curable but
they can be adequately treated, mostly with a long
term, sometimes lifelong therapy or therapeutic com-
binations [1, 2]. Adherence to medication is one of
the critical determinants of the successful manage-
ment of most chronic diseases. Studies, however,
repeatedly emphasize that non-adherence to medica-
tion is very common (30–70%) [3–5]. In case of
inhalative devices the adherence is known to be
lower compared to oral therapies, which is the great-
est challenge in the current maintenance inhalation
therapies [6].
The level of adherence is affected by a number of
factors [7], such as patients’ knowledge of their dis-
ease, the applied therapy, its duration as well as its
expected side effects. Lack of information most likely
results in inappropriate use of the device leading to a
reduction in the anticipated therapeutic effectiveness
which could lead to impaired quality of life of
patients, and increased number of exacerbations and
mortality on the long term [8, 9].
The ever-growing number of inhalation devices with
different instructions of use, varying daily dose schedule
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and the changes in therapy during years can also signifi-
cantly increase the risk of non-adherence. Furthermore,
the underlying disease may worsen and co-morbidities
may appear leading to additional drug therapies [10]. In
the light of this we may conclude that it is a great chal-
lenge for healthcare professionals (HCP) to provide
appropriate information and thus improve patient adher-
ence to prescribed drugs. Patient education is a well-
known need: a study in COPD patients defined patient
education as an interdisciplinary task of paramount
importance [11], several studies observed that there are
common errors in inhaler techniques among patients,
which can be minimized with proper patient education
and regular follow-up [12, 13].
However, the primary authentic source of informa-
tion for the patients is the treating physician, taking
into consideration the different health culture of
patients and the limited time available for a HCP to
provide information, educate and check the feedback
from patients, the role of patient information mate-
rials becomes much more significant [14]. Package
Leaflets provided in the carton of medicinal products -
requirements for the content and format are laid down in
specific regulations worldwide including Europe - are
specific to a medicine and device and do not provide
sufficient information on the disease itself, only describe
the indication, posology and method of administration,
precautions for use and possible side effects of a medicinal
product [15].
Patient information materials may contribute to en-
hanced individual responsibility and disease awareness,
effectiveness of device utilisation as well as the self-
management ability of patients [16]. The importance of
self-management is also emphasized by international
guidelines, as its absence could lead to therapeutic fail-
ure and finally to increased mortality [1, 2].
Prior to surveying, our experience with the currently
used information materials – with the help of an expert
group consisting of pulmonologists – has shown that
the quality of these materials is inconsistent and they are
not up to date. We reached similar conclusions on the
web as well. According to the opinion of the expert
group, which is also confirmed by the results of the
survey, there is less and less time for professional and
appropriately detailed information of patients in the
outpatient departments, pulmonary care units and GPs’
practices, all of them dealing with increasing number
of patients.
Our objective was to explore and evaluate the level
of information patients with asthma and COPD have
regarding their disease and drug therapy, as well as
the opinion and recommendations of the surveyed
groups on the information patients would like to be
and should be aware of. As a result, our aim was to
compile an optimized patient information material
defined by stakeholders.
Methods
In our study anonymous questionnaires were used to
collect data from pulmonologists, asthma nurses, gen-
eral practitioners as well as patients with obstructive
pulmonary disease diagnosed for at least 1 month and
coming for follow-up. The aim of the study was to
find out the requirements on format and content of
an “ideal” patient information material that fulfills the
need of both patients and HCPs treating them. Ques-
tionnaires were completed by 262 pulmonologists,
102 asthma nurses, 321 GPs, and 978 patients be-
tween May and July, 2014. The willingness to provide
answer was shown to be very high in pulmonologists
(74.8%) and it was also good in asthma nurses
(46.4%). The approximately 10% answering rate in
GPs significantly differs from the previous two groups
but it is acceptable in on line surveys.
Patients’ opinion was surveyed with the assistance of
20 pulmonologists (expert group) working in outpatient
departments with high patient numbers. We had
1 month for patient survey. During this period 5 con-
secutive patients could complete the questionnaire on
each day, a total of 978 evaluable patient questionnaires
were collected this way. The patients’ willingness to
complete the questionnaires and their answers did not affect
their medical care in any way.
The design of questionnaires and the number and
type of questions for patients and healthcare profes-
sionals (HCPs) are summarized in Table 1. For com-
parison purposes, we tried to ask questions with
wording consistent and relevant for both patients
and HCPs. Questions are listed in Additional file 1:
Annex 1. Hungarian National Authority for Data
Protection and Freedom of Information was notified
about the data collection and the survey was regis-
tered under no.: NAIH-109154.
There were two significant differences in the question-
naires of each group:
1.) Pulmonologists and nurses were asked how much
time they spend with patients for the first time
(including examination, teaching the use of
inhalation device, patient education, other
administrative tasks) when asthma or COPD
is diagnosed, and later when symptomatic or
asymptomatic patients come for follow-up.
Considering that GPs are not entitled to
diagnose either asthma or COPD in the Hungarian
healthcare system, this question was deleted from
the GP version.
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2.) For HCPs, we also wanted to know what they think
about the methods which could increase the
effectiveness of patient education and what they
consider as key points considering the wide range
of patient information materials currently used,
their advantages and disadvantages and their own
level of competency and training.
Results of this survey were analysed with the
involvement of altogether 46 pulmonologists in
small groups (focus group discussions) conducted 8
times between September and October, 2014. The
statistical analysis was conducted using
R 3.0.1 software (R Core Team) [17]. Comparisons
between groups were performed with analysis of
non-parametric test. Fisher’s exact test and chi-
square test were used to analyse the two dimensional
contingency tables. A value of P < 0.05 was consid-
ered statistically significant.
Results
Patient characteristics
Nine hundred seventy-eight evaluable questionnaires
were filled in by patients with obstructive pulmonary
disease. Their mean age was 57.2 years (+/−12.05 years).
Number of male and female patients was 405 and
573 respectively, 525 of the surveyed patients have
been diagnosed with asthma (mean age 54.8 years)
and 453 of them with COPD (mean age 59.9 years).
There were no significant differences between the
asthma and COPD groups regarding their gender or
age. It is important to take into account the fact that
the majority of surveyed patients belongs to an older
age group, which is likely to affect their views and
opinions on the questioned topics.
Time spent with patient education
In the first point of the survey the question we tried to
answer was the time doctors and nurses spend with pa-
tients during diagnosis and later during follow-up (14).
Follow-up of symptomatic and asymptomatic patients
was differentiated (Table 2). According to the results,
the pulmonologists can spend more than 20 min with a
patient only in 14.5% of cases at the time of diagnosis.
This rate is lower, even if a symptomatic patient comes
for follow-up (11.2%, P = 0.29) and significantly lower if
the patient coming for follow-up is asymptomatic (2.3%,
P < 0.001). A GP usually spends less than 10 min with an
asymptomatic patient (91.9%) and 10 to 15 min with a
symptomatic patient (43.6%). None of the GPs answer-
ing the survey can spend 20 min or more with a patient
if he/she does not have any symptoms. In general, all
surveyed groups spend most of the time with symptom-
atic patients followed by the diagnosis that includes in-
formation on the characteristics of the disease and the
first patient education. They can spend the least time
with the follow-up of asymptomatic patients.
Table 1 Number of questions used in the questionnaire and
topics. For detailed questions see Additional file 1: Annex 1
Topic of question Number of questions
Pulmonologist Asthma
nurse
GP Patient
Examination, administrative and
patient education time
3 3 2a -b
Deed for patient information
material
1 1 1 1
Volume of patient information
material
1 1 1 1
Ratio of text/figures 1 1 1 1
Order of preferred information
channel
1 1 1 1
The 4 most important topics a
patient information material
should include
1 1 1 1
The 4 least important topics not
necessary to be included in a
patient information material
1 1 1 1
Improvement of effectiveness of
patient education
1 1 1 -b
Need for involvement of a
relative of the patient
1 1 1 1
Total number of questions in the
questionnaire
11 11 10 7
aDue to difference in competency the question on underlying diagnosis could
not be used
bNo relevant question could be used
Table 2 Time spent with patients during diagnosis and control
investigations
Time spent with
patienta (min)
Pulmonologists
(%)
Asthma
nurses (%)b
GPs (%)
Diagnosis 1–10 16.8 15.7 -
10–15 42.7 53.0 -
15–20 26.0 19.6 -
>20 14.5 11.7 -
Control, Patient
without symptoms
1–10 58.4 42.2 91.9
10–15 34.7 50.9 6.2
15–20 4.6 6.9 1.9
>20 2.3 0.0 0.0
Control, patient
with symptoms
1–10 7.2 6.9 39.0
10–15 47.7 46.1 43.6
15–20 33.9 31.3 13.7
> 20 11.2 15.7 3.7
a How much time in average they spent with the patient (investigation,
demonstration of the correct usage of inhalation devices, education,
explanation of the disease, background and future perspectives)
b Regarding the increasing number of patients in the practice - sometimes
30 patients a day or more - the asthma nurses actively participate in the
diagnostic process, but the final diagnostic decision is always entitled to
the pulmonologist
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Rationale and preferred format of patient information
material
90% of the surveyed patients would consider additional
patient information materials useful. 96.1% of pulmonol-
ogists, 97.1% of nurses and 94.6% of GPs (the difference
between patients and HCPs is significant P < 0.05) also
support the idea of further information materials in
addition to the consultation.
Printed patient information material was ranked in the
first place by 77.8% of patients, while GPs, pulmonolo-
gists and assistants ranked the printed material on the
first place at a ratio of 88.5%, 79.8%, and 89.2%, respect-
ively, difference between the two groups (patient-HCP)
was significant (P = 0.001). Although older generation of
HCPs (>50 year) preferred the hard copy format and
younger HCPs (< 35 year) favored internet-based mate-
rials, this difference was not statistically significant.
At lower rate but all groups indicated internet as a
second possible source of getting and providing
information while they did not prefer information
delivered on other data storage media. Only 18% of
patients ranked internet-based information (patient
information) on the first place, whereas this rate was
16% amongst HCPs (P < 0.57). We may conclude that
nearly one-fifth of questioned patients would like to
get information primarily from internet, but this need
is only noticed by pulmonologists amongst HCPs, all
other HCPs underestimate this need of patients.
Volume of patient information, text-figure ratio
According to the vast majority of the surveyed patients
(85.4%), patient information materials of 1 to 5 pages
(A5 format without cover page) is considered the most
effective. It may indicate a significant lack of information
(need for information) that 14.6% of patients could accept a
patient information material of 6 to 10 pages. However, longer
materials are not preferred by either patients or HCPs (Fig. 1).
Based on focus group discussions HCPs would not
provide the information materials to their patients as a
whole but in 2 parts at the first two visits (typically
within 1 month). They considered that segmentation of
texts (e.g. by pictures) could contribute to maintain the
attention of the patients. In respect of text and figure
allocation, significant rate of patients (42.2%) prefers a
ratio of 50–50% which is very similar to the opinion of
pulmonologists and GPs. Nearly the same rate of
patients (42.6%) thought they would prefer more text
than figures/pictures in the written patient information.
Based on the above results it is difficult to define the
preference of patients regarding text/figures ratio how-
ever, pulmonologists and GPs would more frequently
use pictures as demonstration and prefer less inform-
ative text in the patient information materials (Fig. 2).
Key points of patient information materials
Prior to compilation of the questionnaire the expert
group of pulmonologist determined the 10 topics they
considered patients might be interested in. Patients and
HCPs could select the most important ones for them
from these topics in our survey.
Table 3 summarizes the responses of patients and
healthcare professionals (HCPs) in total and per speciality.
The most important topics for patients are in decreasing
order of importance: therapeutic options, causes of
disease, triggering and aggravating factors, symptoms,
lifestyle advice, co-morbidities. Topics are the same for
Fig. 1 Percentages on the volume of patient information material
Tomisa et al. Multidisciplinary Respiratory Medicine  (2017) 12:6 Page 4 of 8
HCPs as well but they are different in terms of rank order.
Lifestyle advice is believed much more important by HCPs
compared to patients while patients prefer to get more in-
formation e.g. on symptoms or other therapeutic options.
Taking into consideration that the patient’s needs in terms
of the most important topics are not focused on a single
subject, to avoid loss of information it was recommended
that information cards describing the above topics briefly
should be added to the planned patient information ma-
terial. These cards should be drawn up to shape an inte-
gral part of the main patient information material.
Following proposals were given for the content:
Topics recommended for patient information for
newly diagnosed patients: symptoms; causes of
disease; triggering and aggravating factors; basic
therapeutic options; what to do in case of an asthma/
COPD attack/exacerbation.
Topics recommended for patient information for
returning patients: therapeutic options at advanced
level; life style advice; importance of co-morbidities.
Information cards: importance of inhalation
steroids (asthma); risks associated with long-term use
of inhalation steroids; recognition of exacerbations;
importance of rehabilitation (COPD); respiratory exercises;
alternative therapies; leisure time and sport; pregnancy/
breastfeeding (asthma); importance of diet; allergy and
asthma; importance of regular risk assessment; importance
of regular use of medicines; authentic web portals, assistance
for getting information from internet; patient organisations –
patient clubs; customized therapeutic options today and
possibilities in the future; importance of rapid - short-acting
bronchodilators; role of smoking.
Patients would always be supplemented by an
individual emergency plan: treatment in
emergency, what to do.
Fig. 2 Distribution of picture and text in patient information material as a percentage
Table 3 The full list of topics for patients and HCPs (*HCPs include the opinion of pulmonologists, asthma nurses, and GPs)
Asthma and COPD related topics Patients (%) HCPs* (%) Pulmonologists (%) Asthma nurses (%) GPs (%)
Symptoms 10.8 11.7 12.6 11.1 10.6
Causes of disease 13.0 13.0 12.3 13.8 9.0
Triggering and aggravating factors 11.0 12.4 12.8 11.8 12.5
Diagnostic procedure 5.7 4.9 5.2 5.5 3.9
Therapeutic options 20.4 16.8 17.0 16.4 16.9
Alternative therapy 6.6 7.7 7.4 7.5 8.2
Co-morbidities 9.5 4.6 4.0 5.8 3.9
Deterioration of status 7.2 7.4 6.8 6.1 9.2
Lifestyle advice 10.6 17.2 16.7 18.0 17.0
Sports and free time activity 5.2 6.0 5.2 4.0 8.8
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How to improve the effectiveness of patient information?
Is involvement of relatives useful?
In response to the first question a significant number
of HCPs (39.6%) indicated that their own education
and continued training could bring the most mean-
ingful progress in the improvement in the effective-
ness of communication with the patients. Asthma
nurses would require continued training at the high-
est rate (42.2%) followed by GPs at a similar rate
(40%) and pulmonologists (38.2%).
58.6% of surveyed patients rejected the involvement of
their relatives in the details of treatment, 33.2% welcomed
the idea, and 8.2% was not sure about this question. In
contrast, most of the HCPs considered the involvement of
relatives or at least their information useful, consistently
high rate of questioned GPs (61.1%) deemed it necessary
and 54.2% of pulmonologists and 54.9% of asthma nurses
were of the same opinion.
Discussion
In our research we - with the involvement of the affected
groups (HCPs, patients) - tried to define the characteris-
tics of the ideal patient information material designed
mostly for an older patient age group suffering from
obstructive pulmonary disease. In the present research,
we could aim this patient group based on the average
age of the patients who filled in our questionnaire.
While the need for patient education was shown to be
extremely high both from patients and medical staff, only
a limited time is available for the education and teaching
of the use of inhalation device at the diagnosis and control
the use later during patients’ follow-up. This is a long-
standing, general problem not a country specific one: in
fact, several studies conducted so far led to the same
conclusion - that errors in inhalation technique and
improper therapeutic adherence is a common phenomenon,
however proper patient education and regular follow up can
improve the situation and help to minimize the errors
[12, 13]. With patient information performed in the
most cases in harmonized manner, duties are distrib-
uted among the involved parties increasing thereby the effi-
ciency of the work of pulmonologists and asthma nurses.
As regard the appropriate format, the preference for
printed materials is surprising as state-of-the-art tech-
nology has become part of the everyday life of both
patients and HCPs by now. It might be explained by
the fact that patients may consider that patient infor-
mation materials provided directly by their doctors
are more reliable; additionally, this has been the most
known and most frequently used form in the recent
decades. Additional benefit includes that doctors can
highlight some points in the printed material (import-
ant information, topic) on the spot increasing thereby
the probability that patients may consider the patient
information material as a guidance and useful supple-
mentary information.
The volume of patient information materials was a
critical point. It is a challenge to find the optimum vol-
ume: important questions may be missing from a too
short material leaving uncertainties in the patients;
whereas a too long material may result in loss of interest
or overlooking of some parts by the patient.
For the ratio of text and figures, it is a cardinal obser-
vation that patients - in contrast to the general opinion
of doctors and nurses - mostly preferred more inform-
ative text content. Healthcare professionals would use
pictures and graphical design more than patients. It is
an additional interesting conclusion that the more the
doctors preferred pictures to text, the more they found a
shorter patient information material more reasonable.
Therefore, this group would aim to provide simple,
user-friendly information. There is another difference in
this point between the two groups: GPs and asthma
nurses considered the simplest patient information ma-
terial the best, while pulmonologists generally preferred
more complex contents and larger volume which are
closer to patients’ requirements.
As GPs meet the patients the most often, it is a surprising
result that this group chose the short brochure containing
the most pictures at the highest rate; furthermore, a lower
rate in this group found the use of patient information
material necessary compared to the other groups.
The preferences of the various groups are advisable to
be considered for the most important topics to be in-
cluded in the educational materials. In addition to thera-
peutic options, patients expressed that they would know
more about the cause of disease and the triggering and
aggravating factors. Patients would like to have more
knowledge and avoid any situations that are associated
with exacerbation of the disease. Questioned healthcare
professionals (HCPs) had a somewhat different way of
thinking and they would better help patients primarily
with lifestyle advice focusing on therapeutic options and
warning to aggravating factors. While there is a close
harmony between patients and medical staff in the
selection of important topics, there is a significant
difference in viewpoints of two questions. These are
lifestyle advice and co-morbidities; the former one is
underestimated by patients, and the latter one is under-
estimated by HCPs compared to the other group. Since
patients and doctors found several topics equally import-
ant (a ranking can be defined but no significant differ-
ence could be detected); therefore, a detailed description
of the topics is necessary in an “ideal” patient informa-
tion material.
Based on the results it can be assumed that a
structural revision of the materials currently used would
be subservient in line with the patients’ requirements.
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Rather than the conventional patient information
brochures, a more flexible and adaptable patient infor-
mation material series would be advisable that could be
customized according to patients’ needs and condition.
Not just a new content and format of the patient infor-
mation material would be required, but a series of
publications would also be needed with contents build-
ing on and supplementing each other. The basis of these
series could be a new type of information materials for
“newly diagnosed” patients and another for “returning
patients” with information cards and an emergency plan
(see Fig. 3).
Conclusions
A renewed, optimalized, patient-friendly information
material, compiled in the structure based on the re-
sults of the survey, may result in higher level of
information for patients compared to the current op-
tions. This would probably improve the exchange of
information and communication during doctor-patient
visits as a more informed patient could discuss his/
her problems with the doctor more efficiently and fas-
ter contributing to the improvement of the efficiency of
patient care.
With increase in lifespan, number of patients and ratio
of chronic illnesses, furthermore considering the limited
capacity of healthcare systems we can anticipate that
patient information materials based on similar surveys
will get into focus worldwide.
Certainly, further studies are necessary to test these
optimized information leaflets in the clinical setting.
Assessing the patients’ understanding, adherence to
treatment and clinical endpoints – such as quality of life,
number of exacerbations, mortality – before and after
the introduction of these renewed information materials
could provide further information about the possible
practical benefits.
An important limitation of our study is that the
results cannot be generalized to the overall patient
population, because the majority of the patients who
filled in our questionnaires belong to an older age
group. This could influence our results for the reason
that elderly patients may find it harder to keep up
with the continuous development of technology,
therefore they may prefer the conventional, written
information materials provided by their doctor. A sur-
vey conducted among younger patients most likely
would have shown a preference for easy accessible on
line content. We would like to further investigate this
assumption in the future.
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